Detection and analysis of human serum albumin nanoparticles within phagocytic cells at the resolution of individual live cell or single 3D multicellular spheroid
- 178 Downloads
Since nanoparticles (NPs) have shown great potential in various biomedical applications, live cell response to NPs should be thoroughly explored prior to their in vivo use. In the current study, live cell array (LCA) methodology and unique cell-based assays were used to study the interaction of magnetite (HSA-Mag NP) loaded human serum albumin NPs with phagocytic cells. The LCA enabled cell culturing during HSA-Mag NP accumulation and monolayer or spheroid formation, concomitantly with on-line monitoring of NP internalization. These platforms were also utilized for imaging intercellular links between living cells preloaded with HSA-Mag NP in 2D and 3D resolution. HSA-Mag NP uptake by cells was quantified by imaging, and analyzed using time-resolved measurements. Image analysis of the individual cells in cell populations showed accumulation of HSA-Mag NP by promonocytes and glial cells in a dose- and time-dependent manner. High variability of NP accumulation in individual cells within cell populations, as well as cell subgroups, was evident in both cell types. Following 24 h interaction, uptake of HSA-Mag NP was about 10 times more efficient in glial cells than in activated promonocytes. The presented assays may facilitate detection and analysis of the amount of NPs within individual cells, as well as the rate of NP accumulation and processing in different subsets of living cells. Such data are crucial for estimating predicted drug dosage delivered by NPs, as well as to study possible mechanisms for NP interference with live cells.
KeywordsHuman serum albumin NPs Phagocytic cells Single cell/spheroid Image analysis Targeted drug delivery Nanomedicine
This study was endowed by the Bequest of Moshe-Shimon and Judith Weisbrodt, by the ERA-NET NEURON Transnational Research Project 2009 and by the Israel Ministry of Health.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This manuscript does not contain clinical studies or patient data.
Supplementary material 1 (MP4 1498 kb)
Supplementary material 2 (MP4 593 kb)
- Eustaquio T, Leary JF (2012) Single-cell nanotoxicity assays of superparamagnetic iron oxide nanoparticles. In: Reineke J (ed) Nanotoxicity: methods and protocols. Methods Mol Biol 926:69–85. Humana PressGoogle Scholar
- Ibuki Y, Toyooka T (2012) Nanoparticle uptake measured by flow cytometry. In: Reineke J (ed) Nanotoxicity: methods and protocols, Methods Mol Biol 926:157–166. Humana Press, ISBN: 978-1-62703-001-4 (Print) 978-1-62703-002-1 (Online)Google Scholar
- Kettiger H, Schipanski A, Wick P, Huwyler J (2013) Engineered nanomaterial uptake and tissue distribution: from cell to organism. Int J Nanomed 8:3255–3269Google Scholar
- Kruttwig K, Brueggemann C, Kaijzel E, Vorhagen S, Hilger T, Löwik C, Hoehn M (2009) Development of a three-dimensional in vitro model for longitudinal observation of cell behavior: monitoring by magnetic resonance imaging and optical imaging. Mol Imaging Biol. doi: 10.1007/s11307-009-0289-x Google Scholar
- Meister S, Zlatev I, Stab J, Docter D, Baches S, Stauber RH, Deutsch M, Schmidt R, Ropele S, Windisch M, Langer K, Wagner S, von Briesen H, Weggen S, Pietrzik CU (2013) Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood–brain barrier model. Alzheimers Res Ther 5(6):51. doi: 10.1186/alzrt225 CrossRefGoogle Scholar
- Sebak S, Mirzaei M, Malhotra M, Kulamarva A, Prakash S (2010) Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. Int J Nanomed 5:525–532Google Scholar